Interestingly, the fold-differences between disease groups and CP for serum NfLUmea47:3 was higher compared to the respective CSF levels (serum/CSF: ALS: 21.7/17.0; AD: 7.0/4.3 and GBS: 18.0/4,2). This evidence concerns the gene CP and amyotrophic lateral sclerosis.